Updates are available Erratum dated 2018-01-23
Click to view Erratum: https://doi.org/10.1038/nrclinonc.2018.13
-
Authors
Bradley, Conor A.
,
Salto-Tellez, Manuel
Laurent-Puig, Pierre
Bardelli, Alberto
Rolfo, Christian
Tabernero, Josep
Khawaja, Hajrah A.
Lawler, Mark
Johnston, Patrick G.
Schaeybroeck, Sandra Van
- License Information
-
More Information
Article History
First Online: 4 April 2017
Competing interests
: P.L.P. has received honoraria from Amgen, Astrazeneca Boerhinger–Ingelheim, Integragen, Merck–Serono, Roche and Sanofi. J.T. has served on the advisory boards of Amgen, Bayer, Boehringer–Ingelheim, Celgene, Chugai, Lilly, MSD, Merck–Serono, Novartis, Pfizer, Roche, Sanofi, Symphogen, Taiho, and Takeda. P.G.J. is the founder and holds shares in Almac diagnostics, Fusion and CV6 Therapeutics, and has served as an expert adviser/consultant of Pfizer and Chugai Pharmaceuticals. The other authors declare no competing interests.
